The WACBD is staffed by several internationally recognized researchers and conducts numerous clinical and translational studies. Many of these studies are enabled and enhanced by a strong collaborative relationship with the Research Institute at Bloodworks Northwest and the University of Washington.
American Thrombosis and Hemostasis Network (ATHN) - Transcends
ATHN Transcends is a natural history cohort study focused on participants with congenital or acquired non-neoplastic blood disorders and connective tissue disorders with bleeding tendencies. ATHN Transcends provides clinical researchers with a uniform, secure, unbiased, and enduring method to collect long-term safety and efficacy data to increase knowledge in these important areas of research.
https://athn.org/what-we-do/national-projects/athn-projects-and-research-studies.html
VISIT THE SITE »
Phase III, open-label, single-dose, multi-center multinational trial investigating a serotype 5 adeno-associated viral vector containing the Padua variant of a codon-optimized human factor IX gene (AAV5-hFIXco-Padua, AMT-061) administered to adult subjects with severe or moderately severe hemophilia B
https://clinicaltrials.gov/ct2/show/NCT03569891
VISIT THE SITE »